These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


230 related items for PubMed ID: 19276991

  • 1. Genetic variants in IL-23R and ATG16L1 independently predispose to increased susceptibility to Crohn's disease in a Canadian population.
    Newman WG, Zhang Q, Liu X, Amos CI, Siminovitch KA.
    J Clin Gastroenterol; 2009; 43(5):444-7. PubMed ID: 19276991
    [Abstract] [Full Text] [Related]

  • 2. IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease.
    Dubinsky MC, Wang D, Picornell Y, Wrobel I, Katzir L, Quiros A, Dutridge D, Wahbeh G, Silber G, Bahar R, Mengesha E, Targan SR, Taylor KD, Rotter JI, Western Regional Research Alliance for Pediatric IBD.
    Inflamm Bowel Dis; 2007 May; 13(5):511-5. PubMed ID: 17309073
    [Abstract] [Full Text] [Related]

  • 3. ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients.
    Lakatos PL, Szamosi T, Szilvasi A, Molnar E, Lakatos L, Kovacs A, Molnar T, Altorjay I, Papp M, Tulassay Z, Miheller P, Papp J, Tordai A, Andrikovics H, Hungarian IBD Study Group.
    Dig Liver Dis; 2008 Nov; 40(11):867-73. PubMed ID: 18499543
    [Abstract] [Full Text] [Related]

  • 4. Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians.
    Mahurkar S, Banerjee R, Rani VS, Thakur N, Rao GV, Reddy DN, Chandak GR.
    J Gastroenterol Hepatol; 2011 Apr; 26(4):694-9. PubMed ID: 21155887
    [Abstract] [Full Text] [Related]

  • 5. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands.
    Weersma RK, Zhernakova A, Nolte IM, Lefebvre C, Rioux JD, Mulder F, van Dullemen HM, Kleibeuker JH, Wijmenga C, Dijkstra G.
    Am J Gastroenterol; 2008 Mar; 103(3):621-7. PubMed ID: 18047540
    [Abstract] [Full Text] [Related]

  • 6. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease.
    Roberts RL, Gearry RB, Hollis-Moffatt JE, Miller AL, Reid J, Abkevich V, Timms KM, Gutin A, Lanchbury JS, Merriman TR, Barclay ML, Kennedy MA.
    Am J Gastroenterol; 2007 Dec; 102(12):2754-61. PubMed ID: 17894849
    [Abstract] [Full Text] [Related]

  • 7. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.
    Sventoraityte J, Zvirbliene A, Franke A, Kwiatkowski R, Kiudelis G, Kupcinskas L, Schreiber S.
    World J Gastroenterol; 2010 Jan 21; 16(3):359-64. PubMed ID: 20082483
    [Abstract] [Full Text] [Related]

  • 8. Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children.
    Amre DK, Mack D, Israel D, Morgan K, Lambrette P, Law L, Grimard G, Deslandres C, Krupoves A, Bucionis V, Costea I, Bissonauth V, Feguery H, D'Souza S, Levy E, Seidman EG.
    Am J Gastroenterol; 2008 Mar 21; 103(3):615-20. PubMed ID: 18047539
    [Abstract] [Full Text] [Related]

  • 9. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.
    Okazaki T, Wang MH, Rawsthorne P, Sargent M, Datta LW, Shugart YY, Bernstein CN, Brant SR.
    Inflamm Bowel Dis; 2008 Nov 21; 14(11):1528-41. PubMed ID: 18521914
    [Abstract] [Full Text] [Related]

  • 10. NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease.
    Gazouli M, Pachoula I, Panayotou I, Mantzaris G, Chrousos G, Anagnou NP, Roma-Giannikou E.
    World J Gastroenterol; 2010 Apr 14; 16(14):1753-8. PubMed ID: 20380008
    [Abstract] [Full Text] [Related]

  • 11. Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease.
    Kim SW, Kim ES, Moon CM, Park JJ, Kim TI, Kim WH, Cheon JH.
    Gut; 2011 Nov 14; 60(11):1527-36. PubMed ID: 21672939
    [Abstract] [Full Text] [Related]

  • 12. Classification of genetic profiles of Crohn's disease: a focus on the ATG16L1 gene.
    Grant SF, Baldassano RN, Hakonarson H.
    Expert Rev Mol Diagn; 2008 Mar 14; 8(2):199-207. PubMed ID: 18366306
    [Abstract] [Full Text] [Related]

  • 13. IRGM variants and susceptibility to inflammatory bowel disease in the German population.
    Glas J, Seiderer J, Bues S, Stallhofer J, Fries C, Olszak T, Tsekeri E, Wetzke M, Beigel F, Steib C, Friedrich M, Göke B, Diegelmann J, Czamara D, Brand S.
    PLoS One; 2013 Mar 14; 8(1):e54338. PubMed ID: 23365659
    [Abstract] [Full Text] [Related]

  • 14. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M, Göke B, Folwaczny C, Müller-Myhsok B, Brand S.
    Am J Gastroenterol; 2009 Jul 14; 104(7):1723-33. PubMed ID: 19455129
    [Abstract] [Full Text] [Related]

  • 15. Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach.
    Palomino-Morales RJ, Oliver J, Gómez-García M, López-Nevot MA, Rodrigo L, Nieto A, Alizadeh BZ, Martín J.
    Genes Immun; 2009 Jun 14; 10(4):356-64. PubMed ID: 19491842
    [Abstract] [Full Text] [Related]

  • 16. Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.
    Latiano A, Palmieri O, Corritore G, Valvano MR, Bossa F, Cucchiara S, Castro M, Riegler G, De Venuto D, D'Incà R, Andriulli A, Annese V.
    Inflamm Bowel Dis; 2010 Jul 14; 16(7):1108-17. PubMed ID: 20024904
    [Abstract] [Full Text] [Related]

  • 17. Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene.
    Cummings JR, Cooney R, Pathan S, Anderson CA, Barrett JC, Beckly J, Geremia A, Hancock L, Guo C, Ahmad T, Cardon LR, Jewell DP.
    Inflamm Bowel Dis; 2007 Aug 14; 13(8):941-6. PubMed ID: 17455206
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. DLG5 variants contribute to Crohn disease risk in a Canadian population.
    Newman WG, Gu X, Wintle RF, Liu X, van Oene M, Amos CI, Siminovitch KA.
    Hum Mutat; 2006 Apr 14; 27(4):353-8. PubMed ID: 16450402
    [Abstract] [Full Text] [Related]

  • 20. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5.
    Prescott NJ, Fisher SA, Franke A, Hampe J, Onnie CM, Soars D, Bagnall R, Mirza MM, Sanderson J, Forbes A, Mansfield JC, Lewis CM, Schreiber S, Mathew CG.
    Gastroenterology; 2007 May 14; 132(5):1665-71. PubMed ID: 17484864
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.